Hextend artificial plasma extender: BTIM filed an IND to begin Phase III trials

BioTime Inc. (BTIM), Berkeley, Calif. Product: Hextend artificial plasma extender Indication: Replace blood volume lost in surgery Status: BTIM filed an IND to begin Phase III trials with Hextend to...